Interactive Question 2

May 28, 2013

Question:

Which of the following statements is true regarding the U.S Preventive Services Task Force’s recommendation for aspirin use in the prevention of cardiovascular disease?

Answers

Answer:

aspirin is recommended for men aged 45-54 when potential for preventing a myocardial infarction outweighs potential harm of gastrointestinal hemorrhage.

Correct Answer?

Explanation:

Correct. The USPSTF encourages aspirin use in men aged 45-79 years when potential cardiovascular benefit (myocardial infarctions prevented) outweighs potential harm of gastrointestinal hemorrhage. The USPSTF defines the 10-year coronary heart disease risk level at which cardiovascular events prevented (benefit) exceeds gastrointestinal harms as ≥4% for men aged 45-59 years, ≥ 9% for men aged 60-69 years, and ≥ 12% for menaged 70-79 years.

Answers

Answer:

aspirin is recommended for women aged 45-54 when potential for preventing a stroke outweighs potential harm of gastrointestinal hemorrhage

Correct Answer?

Explanation:

Incorrect. The USPSTF encourages aspirin use in women aged 55-79 years when potential cardiovascular benefit (strokes prevented) outweighs potential harm of gastrointestinal hemorrhage. However, the USPSTF does not encourage aspirin use for stroke prevention in women less than 55 years old. The USPSTF defines the 10-year stroke risk level at which cardiovascular events prevented (benefit) exceeds gastrointestinal harms as ≥ 3% for women aged 55-59 years, ≥ 8% for women aged 60-69 years, and ≥ 11% for women aged 70-79 years.

Answers

Answer:

aspirin is generally recommended for men 80 years or older for the prevention of stroke

Correct Answer?

Explanation:

Incorrect. The USPSTF does not make recommendations for aspirin use for men aged 80 years or older due to insufficient evidence.

Answers

Answer:

aspirin is generally recommended for women 80 years or older for the prevention of myocardial infarction

Correct Answer?

Explanation:

Incorrect. The USPSTF does not make recommendations foraspirin use for women aged 80 years or older due to insufficient evidence.

Format:

Radio buttons (single select)

(781) 893-4610 | General Support: (617) 841-2925 or support@mms.org